Department of Psychology, The Australian National University, Building 39, Canberra, ACT 0200, Australia.
Psychopharmacology (Berl). 2010 Mar;209(1):51-67. doi: 10.1007/s00213-009-1766-2. Epub 2010 Feb 2.
Despite animal evidence that methylenedioxymethamphetamine (ecstasy) causes lasting damage in brain regions related to long-term memory, results regarding human memory performance have been variable. This variability may reflect the cognitive complexity of the memory tasks. However, previous studies have tested only a limited range of cognitive complexity. Furthermore, comparisons across different studies are made difficult by regional variations in ecstasy composition and patterns of use.
The objective of this study is to evaluate ecstasy-related deficits in human verbal memory over a wide range of cognitive complexity using subjects drawn from a single geographical population.
Ecstasy users were compared to non-drug using controls on verbal tasks with low cognitive complexity (stem completion), moderate cognitive complexity (stem-cued recall and word list learning) and high cognitive complexity (California Verbal Learning Test, Verbal Paired Associates and a novel Verbal Triplet Associates test). Where significant differences were found, both groups were also compared to cannabis users.
More cognitively complex memory tasks were associated with clearer ecstasy-related deficits than low complexity tasks. In the most cognitively demanding task, ecstasy-related deficits remained even after multiple learning opportunities, whereas the performance of cannabis users approached that of non-drug using controls. Ecstasy users also had weaker deliberate strategy use than both non-drug and cannabis controls.
Results were consistent with the proposal that ecstasy-related memory deficits are more reliable on tasks with greater cognitive complexity. This could arise either because such tasks require a greater contribution from the frontal lobe or because they require greater interaction between multiple brain regions.
尽管有动物研究证据表明,亚甲二氧基甲基苯丙胺(摇头丸)会对与长期记忆相关的大脑区域造成持久损害,但关于人类记忆表现的结果一直存在差异。这种可变性可能反映了记忆任务的认知复杂性。然而,以前的研究仅测试了有限范围的认知复杂性。此外,由于摇头丸成分和使用模式的区域差异,不同研究之间的比较变得更加困难。
本研究的目的是使用来自单一地理人群的受试者,在广泛的认知复杂性范围内评估与摇头丸相关的人类言语记忆缺陷。
将摇头丸使用者与非药物使用者在认知复杂性较低的言语任务(词干完成)、认知复杂性中等的言语任务(词干提示回忆和单词列表学习)和认知复杂性较高的言语任务(加利福尼亚言语学习测验、言语配对联想和一种新的言语三连体联想测验)上进行比较。如果发现显著差异,还将两组与大麻使用者进行比较。
与认知复杂性较低的任务相比,更复杂的记忆任务与更明显的摇头丸相关缺陷相关。在最具认知挑战性的任务中,即使有多次学习机会,摇头丸相关的缺陷仍然存在,而大麻使用者的表现接近非药物使用者的对照组。摇头丸使用者的刻意策略使用也弱于非药物和大麻对照组。
结果与以下假设一致,即与摇头丸相关的记忆缺陷在认知复杂性较高的任务中更可靠。这可能是因为此类任务需要额叶更大的贡献,或者因为它们需要多个大脑区域之间更大的相互作用。